According to the press release, testosterone supplements like AndroGel can prevent muscle loss, fatigue or erectile dysfunction in critically ill patients suffering from HIV/AIDS, diabetes, and advanced age. The release says the lawsuit contends that Solvay Pharmaceuticals allegedly illegally colluded with three other pharmaceutical companies - Watson, Par and Paddock Laboratories - to keep the three companies from producing generic alternatives to its testosterone supplement. All four companies are defendants in the lawsuit.

The lawsuit seeks to declare the agreements between Solvay, Paddock, Par and Watson illegal and void, permanently enjoin the defendants from similar and related conduct in the future, and fine the defendants $2500 for each prescription and user of AndroGel in California under the California Unfair Competition Act.

Back to HCB News

More Industry Headlines